Moderna (MRNA) to Replace Alexion (ALXN) in S&P 500

(Updated - July 15, 2021 5:18 PM EDT)

Moderna Inc. (NASDAQ: MRNA) will replace Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) in the S&P 500 effective prior to the opening of trading on Wednesday, July 21. AstraZeneca Plc (LSE:AZN; NASDAQ:AZN) is acquiring Alexion Pharmaceuticals in a deal expected to be completed soon pending final closing conditions.

You May Also Be Interested In

• Moderna (MRNA) spreader of 1K contracts of September 25 weekly 157.50 and 165 calls as share price up 10.5%
• BofA sees just 2% upside for the S&P 500 over the next 12 months
• Global S&P Futures up in premarket, Nikkei mixed, Germany mixed, WTI Crude oil recently at $101, natural gas mixed, gold at $4352